Andrew Combs, Chief Chemistry Officer: Prelude Therapeutics PRLD Buy · Filed 25/03/27

Trade details

Type: Insider buy
Amount: $69,000
Shares · price: 100,000 sh · $0.69 a share
Held after: 480,123 sh
Stock: Prelude Therapeutics PRLD
Person: Andrew CombsChief Chemistry Officer
Trade date: 25/03/25
Filed: 25/03/27
Days to filing: 2 days

First buy since 2023

Insiders buying this week: 2 insiders
Holding change: +26.3%

Prelude Therapeutics trades, last 26 weeks

What else happened in Prelude Therapeutics around then

Filed or reported within 30 days of the trade day · 25/02/23~25/04/24

Andrew Combs's recent trades

Andrew CombsChief Chemistry Officer
BuyPrelude Therapeutics
Buy
Prelude Therapeutics
PRLD
$82.2K
60,000 sh
$82.2K
Filed 24/12/26
Traded 24/12/23
Andrew CombsChief Chemistry Officer
BuyPrelude Therapeutics
Buy
Prelude Therapeutics
PRLD
$3,536
3,075 sh
$3,536
Filed 24/12/26
Traded 24/12/20